Analytic Investors’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$2.08M Buy
46,675
+22,258
+91% +$1.08M 0.02% 271
2016
Q2
$1.26M Sell
24,417
-30,838
-56% -$1.47M 0.01% 344
2016
Q1
$2.43M Buy
55,255
+35,206
+176% +$1.39M 0.03% 284
2015
Q4
$944K Sell
20,049
-27,906
-58% -$1.34M 0.01% 402
2015
Q3
$1.9M Buy
47,955
+25,968
+118% +$1.21M 0.03% 297
2015
Q2
$966K Buy
21,987
+9,543
+77% +$395K 0.01% 383
2015
Q1
$493K Sell
12,444
-78,767
-86% -$2.33M 0.01% 449
2014
Q4
$1.97M Buy
91,211
+52,261
+134% +$1.11M 0.03% 253
2014
Q3
$728K Buy
38,950
+2,822
+8% +$60.6K 0.01% 416
2014
Q2
$748K Hold
36,128
0.01% 358
2014
Q1
$682K Hold
36,128
0.01% 408
2013
Q4
$644K Sell
36,128
-14,036
-28% -$242K 0.01% 354
2013
Q3
$662K Sell
50,164
-38,970
-44% -$551K 0.01% 337
2013
Q2
$1.25M Buy
+89,134
New +$1.17M 0.02% 329

Other funds holding CBM

Analytic Investors's CBM Position: Q3 2016 in Review

Analytic Investors increased its Cambrex Corporation (CBM) stake by 91% in Q3 2016, buying an estimated $1.08M and bringing the position to 46,675 shares worth $2.08M. The position accounts for 0.02% of the portfolio, ranked #271.

Analytic Investors first reported a position in CBM in Q2 2013 and has held it in 14 quarters since. The position peaked at $2.43M in Q1 2016. 235 funds tracked by Wall St. Rank hold CBM as of Q3 2016.

  • Analytic Investors held 46,675 shares of Cambrex Corporation worth $2.08M as of Q3 2016.
  • Analytic Investors bought 22,258 Cambrex Corporation shares in Q3 2016, an estimated $1.08M.
  • Cambrex Corporation made up 0.02% of Analytic Investors's portfolio in Q3 2016, its #271 holding.
  • Analytic Investors first reported a position in Cambrex Corporation in Q2 2013 and has held it in 14 quarters since.
  • Analytic Investors's Cambrex Corporation position peaked at $2.43M in Q1 2016.
  • 235 funds tracked by Wall St. Rank held Cambrex Corporation as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.